𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome: a multicenter, open-label, explorative study

✍ Scribed by Yoshiyuki Narahara; Hidenori Kanazawa; Choitsu Sakamoto; Hitoshi Maruyama; Osamu Yokosuka; Satoshi Mochida; Masahito Uemura; Hiroshi Fukui; Yasukiyo Sumino; Yasushi Matsuzaki; Naohiko Masaki; Shigehiro Kokubu; Kiwamu Okita

Book ID
113046963
Publisher
Springer Japan
Year
2011
Tongue
English
Weight
241 KB
Volume
47
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Predictors of response to therapy with t
Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome
✍ AndrΓ© Nazar; Gustavo Henrique Pereira; MΓ³nica Guevara; Marta MartΓ­n-Llahi; Marie πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 169 KB πŸ‘ 1 views

Terlipressin plus albumin is an effective treatment for type 1 hepatorenal syndrome (HRS), but approximately only half of the patients respond to this therapy. The aim of this study was to assess predictive factors of response to treatment with terlipressin and albumin in patients with type 1 HRS. T